UEG's content platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.
Trending on Gutflix
Rate for better recommendations!
Your feedback helps us show you more of what you like and less of what you dislike!
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
INNOVATIVE PROCEDURE FOR GENOTYPIC ANTIBIOTIC SUSCEPTIBILITY TESTING IN GASTRIC ASPIRATES FOLLOWING THE INTRAPROCEDURAL DETECTION OF H. PYLORI BY THE COMBINED ENDOSCOPY/ENDOFASTER METHOD
Riccardo Vasapolli 1,2, Florent Ailloud 3,4, Beate Spiessberger 3,4, Peter Malfertheiner 1, Sebastian Suerbaum 3,4,2, Christian Schulz 1,2
Affiliations
1 University Hospital LMU Munich, Munich, Germany
2 DZIF Deutsches Zentrum für Infektionsforschung, Partner Site Munich, Munich, Germany
3 Max von Pettenkofer Institute, Ludwig Maximilians University of Munich, Munich, Germany
4 National Reference Center for Helicobacter pylori, Munich, Germany
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
A PILOT INVESTIGATION OF THE SAFETY, TOLERABILITY AND EFFECTIVENESS OF RADIOFREQUENCY VAPOR (RFV) ABLATION FOR DUODENAL MUCOSAL ABLATION (DA) FOR THE MANAGEMENT OF TYPE-2 DIABETES MELLITUS (STEAN T-2DM PILOT)
Benjamin Norton 1, Apostolis Papaefthymiou 1, Andrea Telese 1, Alejandro Nieponice 2, Leonardo Rodriguez Grunert 3, Pablo Becerra Hoebel 3, Charlie Murray 1, Kenneth Chang 4, C. Roberto Simons-Linares 5, Rehan Haidry 1
Affiliations
1 Cleveland Clinic London, London, United Kingdom
2 Hospital Universitario, Fundacion Favaloro, Buenos Aires, Argentina
3 Clinica Colonial, Santiago, Chile
4 University of California Irvine, Orange, United States
5 Cleveland Clinic Ohio, Ohio, United States
Log in to continue.
This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.
Not sure what you can access? Learn more about account types.
EFFICACY AND SAFETY OF GUSELKUMAB IN PERIANAL FISTULIZING CROHN’S DISEASE: WEEK 48 RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FUZION TRIAL
Ailsa L Hart 1, Axel Dignass 2, Vipul Jairath 3, Tadakazu Hisamatsu 4, Bruce E. Sands 5, Antonino Spinelli 6,7, Susan Connor 8, André D'Hoore 9, Walter Reinisch 10, Silvio Danese 11, David Schwartzhttps://www.marriott.com/reservation/rateListMenu.mi# 12, Julian Panés 13, Bram Verstockt 14, Anton Stift 15, Maciek Nazar 16, Jacqueline van Denderen 17, Takehiko Sakamoto 18, Koji Masuda 18, Stephen Xu 19, Ivana Bravatà 20, Geert R. D'Haens 21, Laurent Peyrin-Biroulet 22
Affiliations
1 St Mark’s, the National Bowel Hospital, London North-West University Healthcare NHS Trust, London, United Kingdom
2 Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany
3 Department of Medicine, Schulich School of Medicine & Dentistry I, Western University, London, ON, Canada
4 Kyorin University School of Medicine, Tokyo, Japan
5 Dr. Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
6 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
7 IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
8 Department of Gastroenterology, Liverpool Hospital, Liverpool, New South Wales and South West Sydney Clinical Campuses, UNSW Medicine & Health, UNSW Sydney, Sydney, Australia
9 Department of Abdominal Surgery, University Hospitals Leuven, KU Leuven, Leuven, Belgium
10 Clinical Department for Gastroenterology and Hepatology, Internal Medicine Clinic III, Medical University of Vienna, Vienna, Austria
11 IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milano, Italy
12 Inflammatory Bowel Disease Center, Vanderbilt University Medical Center, Nashville, United States
13 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
14 Department of Gastroenterology and Hepatology, University Hospitals Leuven and Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium
15 Department of General Surgery, Division of Visceral Surgery, Medical University Vienna, Vienna, Austria
16 Johnson & Johnson, Warsaw, Poland
17 Johnson & Johnson, Breda, Netherlands
18 Johnson & Johnson, Tokyo, Japan
19 Johnson & Johnson, Spring House, United States
20 Johnson & Johnson, Milan, Italy
21 Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, Netherlands
22 Northwestern Medicine Digestive Health Institute, Chicago, United States